Abstract
In this paper an optimal control model describing the influence of methadone maintenance treatment (MMT) on the spread of blood-borne diseases like Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) among injection drug users is analyzed. The aim of the model is to find the optimal policy to minimize the discounted stream of the overall costs arising from MMT and the social costs caused by new infections from HIV and HCV.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
M. Alter and L. Moyer. The importance of preventing Hepatitis C Virus infection among injection drug users in the United States. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18(Sl):6–10, 1998.
CDC. Recommendations for prevention and control of Hepatitis C Virus (HCV) infection and HCV-related chronic disease. Technical Report 47 (RR 19), MMWR,1998.
T. D’Aunno, T. Vaughn, and P. McElroy. An institutional analysis of HIV prevention efforts by the nations outpatient drug abuse treatment units. Journal of Health and Social Behaviour, 40(2):175–92, 1999.
G.Feichtinger and R.F. Hartl.Optimale Kontrolle ökonomischer Prozesse.Walter de Gruyter,Berlin,1986
G. Feichtinger and G. Tragler. Skiba thresholds in optimal control of illicit drug use. In G. Zaccour, editor, Optimal Control and Differential Games. Kluwer Academic Publisher, Boston, 2002.
D.R. Holtgrave and S.D. Pinkerton. Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology,16(1):54–62, 1997.
M. No Time to Lose: Making the Most of HIV Prevention. National Academy Press, Washington, DC, 2000.
H.A. Pollack. The cost-effectiveness of methadone in preventing blood-borne disease: A comparison of HIV and Hepatitis C. Working Paper, 200s0.
H.A. Pollack. Controlling infectious diseases among injection drug users: Learning (the right) lessons from HIV. Working Paper, 2001.
J.B. Wong. Cost-effectiveness of treatments for chronic Hepatitis C. American Journal of Medicine, 107(6B):74–78, 1999.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Almeder, J. (2003). Optimal Control of Methadone Treatment in Preventing Blood-Borne Disease. In: Leopold-Wildburger, U., Rendl, F., Wäscher, G. (eds) Operations Research Proceedings 2002. Operations Research Proceedings 2002, vol 2002. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55537-4_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-55537-4_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-00387-8
Online ISBN: 978-3-642-55537-4
eBook Packages: Springer Book Archive